Antiretroviral therapy coverage in Middle East, North Africa, Afghanistan & Pakistan
Middle East, North Africa, Afghanistan & Pakistan: Antiretroviral therapy coverage was 28.7% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Middle East, North Africa, Afghanistan & Pakistan, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Middle East, North Africa, Afghanistan & Pakistan recorded 28.7% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
That represents a change of up 5.7% on the previous year and up 114.5% over ten years.
Over the whole period, antiretroviral therapy coverage in Middle East, North Africa, Afghanistan & Pakistan peaked at 28.7% in 2024 and was at its lowest, 3.2%, in 2000.
That places Middle East, North Africa, Afghanistan & Pakistan 21st out of 23 groups with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Middle East, North Africa, Afghanistan & Pakistan, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 3.2% | — |
| 2001 | 3.8% | +18.0% |
| 2002 | 4.2% | +10.5% |
| 2003 | 5.3% | +25.5% |
| 2004 | 5.9% | +12.3% |
| 2005 | 6.2% | +5.4% |
| 2006 | 6.8% | +8.8% |
| 2007 | 6.9% | +1.1% |
| 2008 | 7.8% | +13.3% |
| 2009 | 8.2% | +6.0% |
| 2010 | 8.9% | +8.1% |
| 2011 | 9.2% | +3.7% |
| 2012 | 10.6% | +14.4% |
| 2013 | 11.5% | +8.7% |
| 2014 | 13.4% | +16.7% |
| 2015 | 14.4% | +7.2% |
| 2016 | 16.6% | +15.4% |
| 2017 | 18.6% | +12.4% |
| 2018 | 20.5% | +9.9% |
| 2019 | 22.5% | +9.9% |
| 2020 | 22.4% | -0.4% |
| 2021 | 23.4% | +4.3% |
| 2022 | 24.9% | +6.7% |
| 2023 | 27.2% | +9.0% |
| 2024 | 28.7% | +5.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.8% | 3.2% | 8.2% | 10 |
| 2010s | 14.6% | 8.9% | 22.5% | 10 |
| 2020s | 25.3% | 22.4% | 28.7% | 5 |
Countries ranked near Middle East, North Africa, Afghanistan & Pakistan
More health data for Middle East, North Africa, Afghanistan & Pakistan
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.93 % change on previous year (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.0387 units per person (2025)
- Population ages 40-44, female, annual growth rate 3.33 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 3.14 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0337 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, per capita 0.0344 units per person (2025)
- Population ages 40-44, female, per capita 0.0305 units per person (2025)
All data for Middle East, North Africa, Afghanistan & Pakistan →
Frequently asked questions
- What is antiretroviral therapy coverage in Middle East, North Africa, Afghanistan & Pakistan?
- Antiretroviral therapy coverage in Middle East, North Africa, Afghanistan & Pakistan was 28.7% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Middle East, North Africa, Afghanistan & Pakistan?
- The highest recorded value was 28.7% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Middle East, North Africa, Afghanistan & Pakistan?
- The lowest recorded value was 3.2% in 2000.
- How does Middle East, North Africa, Afghanistan & Pakistan rank for antiretroviral therapy coverage?
- Middle East, North Africa, Afghanistan & Pakistan ranks 21st out of 23 groups with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Middle East, North Africa, Afghanistan & Pakistan?
- Over the last ten years it is up 114.5%. The long-run trend across the full record is volatile.
- Where does this Middle East, North Africa, Afghanistan & Pakistan data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.